QR Kod

A case of Alemtuzumab-induced neutropenia in multiple sclerosis in association with the expansion of large granular lymphocytes

Abstract Background Alemtuzumab has been demonstrated to reduce the risks of relapse and accumulation of sustained disability in Multiple Sclerosis (MS) patients compared to β-interferon. It acts against CD52, leading primarily to lymphopenia. Recent data have shown that mild neutropenia is observed...

Ful tanımlama

Kaydedildi:
Asıl Yazarlar: A. G. Vakrakou, D. Tzanetakos, S. Valsami, E. Grigoriou, K. Psarra, J. Tzartos, M. Anagnostouli, E. Andreadou, M. E. Evangelopoulos, G. Koutsis, C. Chrysovitsanou, E. Gialafos, A. Dimitrakopoulos, L. Stefanis, C. Kilidireas
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BMC 2018-10-01
Seri Bilgileri:BMC Neurology
Konular:
Multiple sclerosis
Alemtuzumab
Neutropenia
Large granular cells
Online Erişim:http://link.springer.com/article/10.1186/s12883-018-1183-4
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller